MNMD
Companies
NASDAQ
Mind Medicine (MindMed) Inc.
Health Care
$7.09
+$0.13 (+1.87%)
Price Chart
Overview
About MNMD
Mind Medicine Inc., also known as MindMed, is a New York-based psychedelic medicine biotech company that develops psychedelic-inspired medicines known as psychoplastogens and therapies to address addiction and mental illness.
Market Cap
$521.1M
Volume
10.9M
Avg. Volume
10.2M
P/E Ratio
-3.9635036
Dividend Yield
0.00%
Employees
48.0
Company Information
Latest News for MNMD
Risk & Correlation Analysis
Market Correlation
1.28
High Correlation
Volatility
High (0.89)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Low Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, MNMD shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$521.1M
Volume10.9M
P/E Ratio-3.96
Dividend Yield0.00%
Important Dates
Next Dividend
February 27, 2020Next Earnings
March 6, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025